Allergy/Imm Medical News about rectal cancer

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer
Histopathology, 09/04/09

Wang Q et al. – The CD133 antigen has been identified as a putative stem cell marker in colorectal cancer tissues. According to the cancer stem cell hypothesis, CD133+ cells determine long–term tumour growth and are therefore suspected of influencing clinical outcome. CD133 stem cell antigen expression correlates with patient survival in rectal cancer, lending support to the current cancer stem cell hypothesis.

<< Previous
Reciprocal effect of mesenchymal stem cell on experimental...

Next >>
Effects of Inhaled Nitric Oxide on Primary Graft Dysfunction in...

Obesity linked to specific cancers
Internet Source, 11/05/09 Relevance Score: 69%

Plasma enterolactone and risk of colon and rectal cancer in a case–cohort study of Danish men and women
Cancer Causes and Control, 10/28/09 Relevance Score: 69%

Childhood Cancer Survivors Experience Suicidal Thoughts Decades After Diagnosis
ScienceDaily, 10/27/09 Relevance Score: 69%

American Cancer Society Stands by Cancer Screening Guidelines
MedLinePlus, 10/23/09 Relevance Score: 69%

New Drug Aims To Seek And Destroy Many Types Of Cancer
ScienceDaily, 10/07/09 Relevance Score: 69%